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TO THE EDITOR
It was surprising to read the recent report
of Cotter et al. (2007) that they were
unable to detect the activity sometimes
called senescence-associated b-galacto-
sidase, which we prefer to call acidic
b-galactosidase, in human melanocytic
nevi. As they say, this finding is in
conflict with two published reports, those
of Michaloglou et al. (2005) and our-
selves (Gray-Schopfer et al., 2006).
There is wide agreement that this
b-galactosidase reaction at pH 6 simply
reflects a high level of lysosomal
b-galactosidase, as we commented
(Gray-Schopfer et al., 2006), citing Kurz
et al. (2000), and as further demons-
trated recently by Lee et al. (2006). It is
present in certain cells besides senescent
cells. For example, as stated in
the original report (Dimri et al., 1995),
growing human melanocytes in culture
can show this reaction at pH 6. We have
also reported this (Sviderskaya et al.,
2002). Thus, the activity alone is not a
sufficient marker for senescence. None-
theless, an unusually high activity of the
enzyme, high enough to react at non-
optimal pH, such as 6, is typical of
senescent cells. Accordingly, this property
remains informative when used as one of
several combined markers for senes-
cence. This is how it was used in the
nevus studies of both Michaloglou et al.,
and ourselves. Both groups also showed
the presence of senescence effector p16;
we additionally reported the common
presence of giant and multinucleate cells
in nevi (Gray-Schopfer et al., 2006), and
nevi have very low levels of the prolif-
erative marker Ki67 (Healy et al., 1998;
Michaloglou et al., 2005), consistent with
the fact that nevi do not grow.
Cotter et al. suggest the possibility
that we did not carefully control the pH
of staining solutions when we obtained
positive staining of nevi. We respect-
fully reply that we did carefully control
pH, temperature, timing, and the con-
centration and quality of reagents.
Moreover, the key point is that condi-
tions exist where acidic (lysosomal)
b-galactosidase activity is detectable
in nevi and not in surrounding cells,
so it would not matter even if the pH
had been erroneous. Cotter et al. ob-
served the same difference themselves
at pH 4, as presented in Figure 1f in
their article: the neighboring epidermis
appears unstained (although the image
resolution is too low to show any other
tissues such as blood vessels). Hence,
despite the title of their letter, they did
detect a ‘‘senescence-associated’’ ac-
tivity, which is simply a high activity.
It is puzzling that Cotter et al. detected
no activity at pH 6 in nevus sections,
whereas both we and Michaloglou et al.
detected it in 100% of congenital nevi
tested. It seems possible that the protocol
of Cotter et al. is less sensitive than those
of Michaloglou et al. and ourselves.
Technical suggestions we can offer are
as follows: staining in the dark, as the
solution is light sensitive, brief fixation (for
sections, we and Dimri et al. took
1minute, and Cotter et al. took 3minutes,
whereas Michaloglou et al. stained before
cutting sections), and longer staining,
which can increase intensity (we took
24hours, whereas they took 16hours). In
the case of cultures, optimized bright-field
optics give best sensitivity, since phase-
contrast optics mask colors. Another vari-
able for frozen specimens is rate of freez-
ing. For example, in thick nevus speci-
mens, we sometimes found activity only
in the superficial part of the nevus, with
the color fading out in the deeper area
(Gray-Schopfer, 2003). This may reflect
loss of activity during slower freezing.
We have also recently observed
b-galactosidase activity at pH 7 in 5/5
cultures explanted from acquired
benign nevi (JK Soo, unpublished data,
to form part of a separate report), an
even higher pH at which senescent but
not growing cultured human melano-
cytes show activity (Gray-Schopfer,
2003). This also confirms that the
activity is not limited to congenital nevi.
In summary, melanocytic nevus cells do
show high acidic b-galactosidase acti-
vity, and at least a large proportion of the
cells in such a lesion are senescent.
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